Skip To Main Content
Shiv Sarin on Muck Rack

Shiv Sarin

As seen in: MSN India, Color Research & Application, Nature, Wiley Online Library, Hindustan Times, MDPI, India Today, The Lancet, MedPage Today, DailyO and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shiv

Contact Shiv, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Urine microscopy can identify cholemic nephropathy as a distinct form of kidney dysfunction in patients with acute on chronic liver failure

|
By Rakhi Maiwall, gaurav tripathi, Archana Rastogi, Deepanshu Maheshwari, Dhananjay Kumar, Jaswinder Singh Maras, Meenu Bajpai, Anupam Kumar, Vaishnavi Rathi, Richard Moreau, Shiv Sarin, Ashini Kumar Hidam
| Nature Verified
Abstract Cholemic nephropathy(CN) is an unrecognized cause of kidney dysfunction in patients with acute on chronic liver failure (ACLF). We aimed to evaluate whether urine microscopy(UM) could identify CN in ACLF patients and differentiate from hepatorenal syndrome (HRS) and acute tubular necrosis (ATN).
Open in Who Shared Issue with article?

Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease - Nature Reviews Gastroenterology & Hepatology

|
By Luis Diaz, Maja Thiele, Alexandre Louvet, Brian Lee, Veeral Ajmera, Federica Tavaglione, Cynthia Hsu, Ramon Bataller, Mack C. Mitchell, Mary E. Rinella, Shiv Sarin, Vijay Shah, Meena B. Bansal, Lorenzo Leggio, Patrick S. Kamath, Aleksander Krag, Arun J Sanyal, Juan Pablo Arab, Quentin M Anstee
| Nature Verified
Abstract Metabolic and alcohol-related liver disease (MetALD) is a newly defined entity within the spectrum of steatotic liver disease, characterized by the interplay of cardiometabolic risk factors and alcohol consumption. The evolving epidemiology and complex pathophysiology of MetALD present unique challenges and opportunities for clinical trial design.
Open in Who Shared Issue with article?

India's continued response to tackling metabolic disorders and non-communicable diseases

|
By Shiv Sarin
| The Lancet Verified
FREE with registration! Log in or register to access the full article. References 1. Press Information Bureau, Government of India Union Health Ministry releases revised operational guidelines and training manual of non-alcoholic fatty liver disease Press Information Bureau, Government of India, 2024 2.
Open in Who Shared Issue with article?
See all 20 licensed articles (22 Total)